Publicaciones

Aportes más relevantes en los cuales participamos

Targeting galectin-driven regulatory circuits in cancer and fibrosis. Mariño KV, Cagnoni AJ, Croci DO, Rabinovich GA. Nat Rev Drug Discov. 2023 Apr;22(4):295-316. doi: 10.1038/s41573-023-00636-2. Epub 2023 Feb 9.

Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology. Bannoud N, Stupirski JC, Cagnoni AJ, Hockl PF, Pérez Sáez JM, García PA, Mahmoud YD, Gambarte Tudela J, Scheidegger MA, Marshall A, Corrie PG, Middleton MR, Mariño KV, Girotti MR, Rabinovich GA, Croci DO. Proc Natl Acad Sci U S A. 2023 Jan 17;120(3):e2214350120. doi: 10.1073/pnas.2214350120.

Untangling Galectin-Mediated Circuits that Control Hypoxia-Driven Angiogenesis.Bannoud N, García PA, Gambarte-Tudela J, Sundblad V, Cagnoni AJ, Bach CA, Pérez Saez JM, Blidner AG, Maller SM, Mariño KV, Salatino M, Cerliani JP, Rabinovich GA, Croci DO. Methods Mol Biol. 2022;2442:635-653. doi: 10.1007/978-1-0716-2055-7_34.

Galectins as potential therapeutic targets in STIs in the female genital tract. Lujan AL, Croci DO, Rabinovich GA, Damiani MT. Nat Rev Urol. 2022 Apr;19(4):240-252. doi: 10.1038/s41585-021-00562-1

Hypoxia Supports Differentiation of Terminally Exhausted CD8 T Cells.  Bannoud N, Dalotto-Moreno T, Kindgard L, García PA, Blidner AG, Mariño KV, Rabinovich GA, Croci DO. Front Immunol. 2021 May 7;12:660944. doi: 10.3389/fimmu.2021.660944. eCollection 2021

Characterization of a neutralizing anti-human galectin-1 monoclonal antibody with angioregulatory and immunomodulatory activities. Pérez Sáez JM, Hockl PF, Cagnoni AJ, Méndez Huergo SP, García PA, Gatto SG, Cerliani JP, Croci DO, Rabinovich GA. Angiogenesis. 2021 Feb;24(1):1-5. doi: 10.1007/s10456-020-09749-3.

Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors. DO. Croci, JP. Cerliani, T Dalotto-Moreno, et al. Cell. 2014 156:744-758.

Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma. DO. Croci, M Salatino, et al. J. Exp. Med. 2012. 209:1985-2000

Capítulos de Libro

Immune-mediated and hypoxia-regulated programs: accomplices in resistance to anti-angiogenic therapies. Croci DO, Mendez-Huergo SP, Cerliani JP, Rabinovich GA. Handb Exp Pharmacol. 2018. 249:31-61

Advances in immunobiology: integrating the universe of effector and regulatory cells. Gabriel A. Rabinovich, Susana Pesoa & Diego Croci. In “Clinical Neuroimmunology”. 1st.Ed,2010. Correale, Vila, Garcea, Eds. Editorial Médica Panamericana; Buenos Aires.  ISBN 9789500601566.

Inmunología Tumoral. Mariana Salatino, Diego Croci, Juan Ilarregui y Gabriel Rainovich. En, Introduccion a la Inmunología Humana- Leonardo Fainboim, Jorge Geffner-  8va. Ed, 2018. Editorial Médica Panamericana; Buenos Aires.

Lista completa de publicaciones: https://pubmed.ncbi.nlm.nih.gov/?term=Croci+DO